Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Arch Surg. 2012 Sep;147(9):820-7. doi: 10.1001/archsurg.2012.1261.

Lymph nodes and survival in pancreatic neuroendocrine tumors.

Author information

  • 1Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305-5655, USA.

Abstract

HYPOTHESIS:

Lymph node metastases decrease survival in patients with pancreatic neuroendocrine tumors (pNETs).

DESIGN:

Prospective database searches.

SETTING:

National Institutes of Health (NIH) and Stanford University Hospital (SUH).

PATIENTS:

A total of 326 patients underwent surgical exploration for pNETs at the NIH (n = 216) and SUH (n = 110).

MAIN OUTCOME MEASURES:

Overall survival, disease-related survival, and time to development of liver metastases.

RESULTS:

Forty patients (12.3%) underwent enucleation and 305 (93.6%) underwent resection. Of the patients who underwent resection, 117 (35.9%) had partial pancreatectomy and 30 (9.2%) had a Whipple procedure. Forty-one patients also had liver resections, 21 had wedge resections, and 20 had lobectomies. Mean follow-up was 8.1 years (range, 0.3-28.6 years). The 10-year overall survival for patients with no metastases or lymph node metastases only was similar at 80%. As expected, patients with liver metastases had a significantly decreased 10-year survival of 30% (P < .001). The time to development of liver metastases was significantly reduced for patients with lymph node metastases alone compared with those with none (P < .001). For the NIH cohort with longer follow-up, disease-related survival was significantly different for those patients with no metastases, lymph node metastases alone, and liver metastases (P < .001). Extent of lymph node involvement in this subgroup showed that disease-related survival decreased as a function of the number of lymph nodes involved (P = .004).

CONCLUSIONS:

As expected, liver metastases decrease survival of patients with pNETs. Patients with lymph node metastases alone have a shorter time to the development of liver metastases that is dependent on the number of lymph nodes involved. With sufficient long-term follow-up, lymph node metastases decrease disease-related survival. Careful evaluation of number and extent of lymph node involvement is warranted in all surgical procedures for pNETs.

Comment in

PMID:
22987171
[PubMed - indexed for MEDLINE]
PMCID:
PMC3448121
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems Icon for PubMed Central
    Loading ...
    Write to the Help Desk